Navigation Links
Can Fertility Treatments Influence Later Breast Cancer Risk?

FRIDAY, July 6 (HealthDay News) -- Whether or not a woman becomes pregnant while on fertility drugs may affect her odds for breast cancer later on, a new study suggests.

However, experts who reviewed the study said it has flaws and is far from conclusive.

In the study, published July 6 in the Journal of the National Cancer Institute, women using ovulation-stimulating fertility drugs who were unable to get pregnant for at least 10 weeks had a lower risk of the disease than women who have not taken the drugs, the U.S. study found.

On the other hand, the odds of breast cancer rose for women who became pregnant for at least 10 weeks after taking the fertility drugs, when compared to women who were unsuccessfully treated with these drugs.

However, the risk for women who became pregnant while on fertility drugs rose only high enough to put it on par with women who had never taken fertility drugs, the researchers noted.

The researchers, led by Chunyuan Fei, at the U.S. National Institute of Environmental Health Sciences, examined women diagnosed with breast cancer before the age of 50, as well as their sisters who did not have the disease, over the course of two years.

"Our data suggest that exposure to a stimulated pregnancy is enough to undo the reduction in [breast cancer] risk associated with a history of exposure to ovulation-stimulating drugs," the authors wrote.

The study's authors pointed out that the study was limited by its reliance on the participants' self-reported fertility drug usage, and a lack of information on each woman's specific diagnosis for infertility. The study is also complicated by the fact that it focuses on women who developed breast cancer before the age of 50, and these tumors are often associated with genetic factors.

In an accompanying editorial, Louise Brinton, of the division of cancer epidemiology and genetics at the U.S. National Cancer Institute, noted that the effects of one fertility drug are similar to an established drug long used to prevent cancer -- a finding that could help explain the study results.

Still, Brinton believes more research is needed to understand the link between breast cancer risk and fertility drugs.

Two other experts took issue with the study's methodology.

"It is hard to draw a conclusion as to whether or not treatment for infertility increases the risk of breast cancer from this study," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. She said these types of cases-vs.-control group studies are somewhat unreliable, and she pointed out that while some prior studies looking at fertility drugs and breast cancer have found a link, others have not.

"One of the ways to reach a better conclusion would be the creation of a national data bank where information on women undergoing treatment is entered and updated as time progresses," Bernik said. "This is an important question to answer, and better methods of obtaining the information need to be established."

For his part, Dr. Paul Tartter, a breast surgeon at St. Luke's & Roosevelt Hospital Center in New York City, noted that "previous studies have not found an increased risk [of breast cancer for women on fertility treatment]. Only one previous study noted a slightly increased risk, which was not statistically significant."

He also took issue with the choice of control group included in the study.

"The control group for these women should be women of the same age who became pregnant without IVF -- they did not use the correct control group. Using the patients' sisters is irrelevant," Tartter explained. Furthermore, "the cases had significantly younger age at menarche [onset of menstruation] and older age at first birth, both well-known risk factors for breast cancer. Nowhere in this study did they control for these differences."

More information

The American College of Obstetricians and Gynecologists provides more information on infertility treatments.

-- Mary Elizabeth Dallas

SOURCE: Stephanie Bernik, MD, chief, surgical oncology, Lenox Hill Hospital, New York City; Paul Tartter, MD, breast surgeon, St. Luke's & Roosevelt Hospital Center, New York City; Oxford University Press, news release, July 6, 2012.

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
2. Heavy Coffee Intake May Affect Fertility Treatments: Study
3. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
4. Success of fertility treatment may approach natural birth rate
5. Under Right Conditions, Fertility Treatment Can Equal Natural Conception Rates: Study
6. Could Fertility Drugs Make Kids Shorter?
7. Men and Women With Cancer May Receive Different Fertility Information
8. Men and women receive different fertility advice following cancer diagnosis
9. New animal model may lead to treatments for common liver disease
10. A better way to test new treatments? Approach could help patients and give useful results
11. Few Migraine Sufferers Referred for Behavioral Treatments
Post Your Comments:
Related Image:
Can Fertility Treatments Influence Later Breast Cancer Risk?
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: